Post Traumatic Stress Disorder Trials Should Use Fixed Dose, Committee Says
Executive Summary
Sponsors seeking a post traumatic stress disorder indication should conduct fixed-dose studies, FDA's Psychopharmacologic Drugs Advisory Committee advised during its Oct. 8 review of Pfizer's Zoloft.